机构:[1]Guangzhou Univ Chinese Med, Clin Coll 2, Guangzhou 510120, Peoples R China广东省中医院[2]Guangzhou Univ Chinese Med, Affiliated Guangzhou Hosp TCM, Guangzhou, Peoples R China[3]Guangzhou Univ Chinese Med, Maoming Hosp, Guangzhou, Peoples R China[4]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China广东省中医院[5]Guangdong Key Lab Clin Res Chinese Med, Guangzhou, Peoples R China[6]Guangdong Joint Lab Guangdong Hong Kong & Macao Ch, Guangzhou, Peoples R China[7]State Key Lab Wet Certificate Chinese Med Jointly, Guangzhou, Peoples R China
ObjectiveCarcinoid syndrome (CS) commonly results from neuroendocrine tumors. While active substances are recognized as the main causes of the typical symptoms such as diarrhea and skin flush, the cause-and-effect relationship between gut microbiota abundance and CS remains unclear.MethodsThe Single Nucleotide Polymorphisms (SNPs) related to gut microbiota abundance and CS were obtained from the GWAS summary data. The inverse variance weighted (IVW) method was used to assess the causal relationship between gut microbiota abundance and CS. Additionally, the MR-Egger, Weighted Median model, and Weighted model were employed as supplementary approaches. The heterogeneity function of the TwoSampleMR package was utilized to assess whether SNPs exhibit heterogeneity. The Egger intercept and Presso test were used to assess whether SNPs exhibit pleiotropy. The Leave-One-Out test was employed to evaluate the sensitivity of SNPs. The Steiger test was utilized to examine whether SNPs have a reverse causal relationship. A bidirectional mendelian randomization (MR) study was conducted to elucidate the inferred cause-and-effect relationship between gut microbiota abundance and CS.ResultsThe IVW results indicated a causal relationship between 6 gut microbiota taxa and CS. Among the 6 gut microbiota taxa, the genus Anaerofilum (IVW OR: 0.3606, 95%CI: 0.1554-0.8367, p-value: 0.0175) exhibited a protective effect against CS. On the other hand, the family Coriobacteriaceae (IVW OR: 3.4572, 95%CI: 1.0571-11.3066, p-value: 0.0402), the genus Enterorhabdus (IVW OR: 4.2496, 95%CI: 1.3314-13.5640, p-value: 0.0146), the genus Ruminiclostridium6 (IVW OR: 4.0116, 95%CI: 1.2711-12.6604, p-value: 0.0178), the genus Veillonella (IVW OR: 3.7023, 95%CI: 1.0155-13.4980, p-value: 0.0473) and genus Holdemanella (IVW OR: 2.2400, 95%CI: 1.0376-4.8358, p-value: 0.0400) demonstrated a detrimental effect on CS. The CS was not found to have a reverse causal relationship with the above 6 gut microbiota taxa.ConclusionSix microbiota taxa were found to have a causal relationship with CS, and further randomized controlled trials are needed for verification.
基金:
Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Guangzhou University of Traditional Chinese Medicine's "Double First Class"; High-level university discipline collaborative innovation team: Traditional Chinese Medicine Reverse Lung Cancer Resistance Innovation Team [2021xk60]
第一作者机构:[1]Guangzhou Univ Chinese Med, Clin Coll 2, Guangzhou 510120, Peoples R China
通讯作者:
通讯机构:[4]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China[5]Guangdong Key Lab Clin Res Chinese Med, Guangzhou, Peoples R China[6]Guangdong Joint Lab Guangdong Hong Kong & Macao Ch, Guangzhou, Peoples R China[7]State Key Lab Wet Certificate Chinese Med Jointly, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Zhang Zexin,Li Dongting,Xie Fengxi,et al.The cause-and-effect relationship between gut microbiota abundance and carcinoid syndrome: a bidirectional Mendelian randomization study[J].FRONTIERS IN MICROBIOLOGY.2023,14:doi:10.3389/fmicb.2023.1291699.
APA:
Zhang, Zexin,Li, Dongting,Xie, Fengxi,Muhetaer, Gulizeba&Zhang, Haibo.(2023).The cause-and-effect relationship between gut microbiota abundance and carcinoid syndrome: a bidirectional Mendelian randomization study.FRONTIERS IN MICROBIOLOGY,14,
MLA:
Zhang, Zexin,et al."The cause-and-effect relationship between gut microbiota abundance and carcinoid syndrome: a bidirectional Mendelian randomization study".FRONTIERS IN MICROBIOLOGY 14.(2023)